testicular%20cancer
TESTICULAR CANCER

Testicular cancer is a rare neoplasm that arises from the testis. It commonly presents as a painless testicular mass.

It has high prevalence in young and middle-aged men in the age of 15-40 years old.

It is a highly treatable disease with a high cure rate.

Testicular primary germ cell tumors coming from the malignant transformation of primordial germ cells make up 95% of all testicular cancer.

 

Radiotherapy

Seminoma

  • Seminomas are radiosensitive & adjuvant radiation therapy to para-aortic & ipsilateral iliac lymph nodes reduces relapse rate to 1-3%
  • Treatment should begin once the orchiectomy wound has completely healed & it should be given w/ a scrotal shield in all patients except in those who underwent bilateral orchiectomy

Stage I

  • Adjuvant radiation therapy to include para-aortic nodes may be considered for patients who are not candidates for chemotherapy
    • Careful consideration must be made for patients <40 yr due to increased risk of radiation-induced secondary malignancies 
  • For stage IS, primary treatment is w/ radiation
    • Repeat tumor markers & obtain an abdominal/pelvic CT for assessment of extent of disease
    • If w/ recurrence, treat based on disease extent at relapse; persistently elevated tumor markers are treated w/ chemotherapy similar to that of nonseminoma

Stage II

  • Nonbulky retroperitoneal disease is treated alternatively w/ radiation therapy to include para-aortic & ipsilateral iliac lymph nodes
    • It is preferred for stage IIA seminoma (lymph node mass <2 cm)
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 07 Aug 2018

While the use of a mesh for pelvic organ prolapse repair resulted in an elevated risk of repeat surgery compared with native tissue repair, the mesh itself did not influence the need for repeat procedure, according to a US-based study.